GOUT AND HYPERURICEMIA
Clinical trials for GOUT AND HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new GOUT AND HYPERURICEMIA trials appear
Sign up with your email to follow new studies for GOUT AND HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gout pill aims to tame uric acid in Mid-Stage trial
Disease control Not yet recruitingThis study tests a new tablet called BR2251 to see if it safely lowers uric acid levels in people with gout and high uric acid. About 160 adults aged 18 to 75 will receive either a low, medium, or high dose of BR2251 or a control drug for 12 weeks. The goal is to find the best do…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
Diabetes drug shows promise for gout in new trial
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug used for diabetes, can lower uric acid levels and reduce inflammation in people with gout. Sixty adults with gout and high urate levels will receive either empagliflozin or a placebo for 12 weeks. The goal is to see if this drug can …
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Genetic screening could stop deadly drug reactions in gout patients
Prevention Not yet recruitingThis study tests whether checking a person's genes before prescribing the gout drug allopurinol can prevent rare but life-threatening skin reactions. About 228 Vietnamese adults with gout will either get the genetic test or standard care. Those with a high-risk gene will receive …
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated May 26, 2026 07:07 UTC